During the last 2 decades, the treatment of hyperglycemia in critically ill patients has become one of the most discussed topics in the intensive medicine field. The initial data suggesting significant benefit of normalization of blood glucose levels in critically ill patients using intensive intravenous insulin therapy have been challenged or even neglected by some later studies. At the moment, the need for glucose control in critically ill patients is generally accepted yet the target glucose values are still the subject of ongoing debates. In this review, we summarize the current data on the benefits and risks of tight glucose control in critically ill patients focusing on the novel technological approaches including continuous glucose monitoring and its combination with computer-based algorithms that might help to overcome some of the hurdles of tight glucose control. Since increased risk of hypoglycemia appears to be the major obstacle of tight glucose control, we try to put forward novel approaches that may help to achieve optimal glucose control with low risk of hypoglycemia. If such approaches can be implemented in real-world practice the entire concept of tight glucose control may need to be revisited.

3rd Department of Medicine Charles University Prague 1st Faculty of Medicine and General University Hospital Prague Czech Republic

Department of Anaesthesia Resuscitation and Intensive Medicine Charles University Prague 1st Faculty of Medicine and General University Hospital Prague Czech Republic

See more in PubMed

Vanhorebeek I, Langouche L, Van den Berghe G. Modulating the endocrine response in sepsis: insulin and blood glucose control. Novartis Found Symp. 2007;280:204-215; discussion 15-22. PubMed

Van den Berghe G. Endocrinology in intensive care medicine: new insights and therapeutic consequences. Verh K Acad Geneeskd Belg. 2002;64:167-187; discussion 87-88. PubMed

Coursin DB, Connery LE, Ketzler JT. Perioperative diabetic and hyperglycemic management issues. Crit Care Med. 2004;32:S116-S125. PubMed

Mizock BA. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res. 2001;15:533-551. PubMed

Bagshaw SM, Egi M, George C, et al. Early blood glucose control and mortality in critically ill patients in Australia. Crit Care Med. 2009;37:463-470. PubMed

Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med. 2008;36:3008-3013. PubMed

Weekers F, Giulietti AP, Michalaki M, et al. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology. 2003;144:5329-5338. PubMed

Schetz M, Vanhorebeek I, Wouters PJ, et al. Tight blood glucose control is renoprotective in critically ill patients. J Am Soc Nephrol. 2008;19:571-578. PubMed PMC

Sanap MN, Worthley LI. Neurologic complications of critical illness: part II. Polyneuropathies and myopathies. Crit Care Resusc. 2002;4:133-140. PubMed

Grey NJ, Perdrizet GA. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract. 2004;10 Suppl 2:46-52. PubMed

Blondet JJ, Beilman GJ. Glycemic control and prevention of perioperative infection. Curr Opin Crit Care. 2007;13:421-427. PubMed

Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA. 2003;290:2041-2047. PubMed

Krinsley JS. Glycemic control, diabetic status, and mortality in a heterogeneous population of critically ill patients before and during the era of intensive glycemic management: six and one-half years experience at a university-affiliated community hospital. Semin Thorac Cardiovasc Surg. 2006;18:317-325. PubMed

van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. New Engl J Med. 2001;345:1359-1367. PubMed

Soop M, Nygren J, Thorell A, Ljungqvist O. Stress-induced insulin resistance: recent developments. Curr Opin Clin Nutr Metab Care. 2007;10:181-186. PubMed

Zimmerman CR, Mlynarek ME, Jordan JA, et al. An insulin infusion protocol in critically ill cardiothoracic surgery patients. Ann Pharmacother. 2004;38:1123-1129. PubMed

Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009;35:1738-1748. PubMed

Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. New Engl J Med. 2009;360:1283-1297. PubMed

Devos P, Preiser JC. Is it time for implementation of tight glycaemia control by intensive insulin therapy in every ICU? Crit Care. 2006;10:130. PubMed PMC

De Block C, Manuel-y-Keenoy B, Rogiers P, et al. Glucose control and use of continuous glucose monitoring in the intensive care unit: a critical review. Curr Diabetes Rev. 2008;4:234-244. PubMed

Ichai C, Preiser JC, Societe Francaise dA-R, et al. International recommendations for glucose control in adult non diabetic critically ill patients. Crit Care. 2010;14:R166. PubMed PMC

Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180:821-827. PubMed PMC

Blaha J, Kopecky P, Matias M, et al. Comparison of three protocols for tight glycemic control in cardiac surgery patients. Diabetes Care. 2009;32:757-761. PubMed PMC

Andreelli F, Jacquier D, Troy S. Molecular aspects of insulin therapy in critically ill patients. Curr Opin Clin Nutr Metab Care. 2006;9:124-130. PubMed

Langley J, Adams G. Insulin-based regimens decrease mortality rates in critically ill patients: a systematic review. Diabetes Metab Res Rev. 2007;23:184-192. PubMed

Van den Berghe G. Insulin therapy for the critically ill patient. Clin Cornerstone. 2003;5:56-63. PubMed

Kanji S, Singh A, Tierney M, et al. Standardization of intravenous insulin therapy improves the efficiency and safety of blood glucose control in critically ill adults. Intensive Care Med. 2004;30:804-810. PubMed

Hovorka R, Kremen J, Blaha J, et al. Blood glucose control by a model predictive control algorithm with variable sampling rate versus a routine glucose management protocol in cardiac surgery patients: a randomized controlled trial. J Clin Endocrinol Metab. 2007;92:2960-2964. PubMed

Hovorka R, Chassin LJ, Wilinska ME, et al. Closing the loop: the adicol experience. Diabetes Technol Ther. 2004;6:307-318. PubMed

Plank J, Blaha J, Cordingley J, et al. Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive care unit patients: response to Ligtenberg, et al. Diabetes Care. 2006;29:1987-1988. PubMed

Meijering S, Corstjens AM, Tulleken JE, et al. Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature. Crit Care. 2006;10:R19. PubMed PMC

Preiser JC, Devos P, Van den Berghe G. Tight control of glycaemia in critically ill patients. Curr Opin Clin Nutr Metab Care. 2002;5:533-537. PubMed

Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes. 2006;55:3151-3159. PubMed

Aragon D. Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control. Am J Crit Care. 2006;15:370-377. PubMed

De Block C, Manuel-y-Keenoy B, Van Gaal L. A review of current evidence with continuous glucose monitoring in patients with diabetes. J Diabetes Sci Technol. 2008;2:718-727. PubMed PMC

Basu A, Dube S, Slama M, et al. Time lag of glucose from intravascular to interstitial compartment in humans. Diabetes. 2013;62:4083-4087. PubMed PMC

Kao LS, Meeks D, Moyer VA, Lally KP. Peri-operative glycaemic control regimens for preventing surgical site infections in adults. Cochrane Database Syst Rev. 2009:CD006806. PubMed PMC

Lazar HL, Chipkin SR, Fitzgerald CA, et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation. 2004:1497-1502. PubMed

Gandhi GY, Nuttall GA, Abel MD, et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med. 2007;146:233-243. PubMed

Hua J, Chen G, Li H, et al. Intensive intraoperative insulin therapy versus conventional insulin therapy during cardiac surgery: a meta-analysis. J Cardiothorac Vasc Anesth. 2012;26:829-834. PubMed

Kopecky P, Mraz M, Lips M, et al. Perioperative initiation of tight glucose control reduces postoperative adverse events in elective cardiac surgery patients: a randomized controlled trial. Diabetes. 2013;62:A81.

De Block C, Manuel YKB, Van Gaal L, Rogiers P. Intensive insulin therapy in the intensive care unit: assessment by continuous glucose monitoring. Diabetes Care. 2006;29:1750-1756. PubMed

Ellmerer M, Haluzik M, Blaha J, et al. Clinical evaluation of alternative-site glucose measurements in patients after major cardiac surgery. Diabetes Care. 2006;29:1275-1281. PubMed

Finfer S, Wernerman J, Preiser JC, et al. Clinical review: consensus recommendations on measurement of blood glucose and reporting glycemic control in critically ill adults. Crit Care. 2013;17:229. PubMed PMC

Kopecky P, Mraz M, Blaha J, et al. The use of continuous glucose monitoring combined with computer-based eMPC algorithm for tight glucose control in cardiosurgical ICU. BioMed Res Int. 2013;2013:186439. PubMed PMC

Leelarathna L, English SW, Thabit H, et al. Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial. Crit Care. 2013;17:R159. PubMed PMC

Siegelaar SE, Barwari T, Hermanides J, et al. Microcirculation and its relation to continuous subcutaneous glucose sensor accuracy in cardiac surgery patients in the intensive care unit. J Thorac Cardiovasc Surg. 2013;146:1283-1289. PubMed

Leelarathna L, English SW, Thabit H, et al. Accuracy of subcutaneous continuous glucose monitoring in critically ill adults: improved sensor performance with enhanced calibrations. Diabetes Technol Ther. 2014;16:97-101. PubMed PMC

Blixt C, Rooyackers O, Isaksson B, Wernerman J. Continuous on-line glucose measurement by microdialysis in a central vein. A pilot study. Crit Care. 2013;17:R87. PubMed PMC

Zander R, Boldt J, Engelmann L, et al. [The design of the VISEP trial. Critical appraisal]. Anaesthesist. 2007;56:71-77. PubMed

Van den Berghe G. Intensive insulin therapy in the ICU—reconciling the evidence. Nature Rev Endocrinol. 2012;8:374-378. PubMed

Lonborg J, Vejlstrup N, Kelbaek H, et al. Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction. Eur Heart J. 2012;33:1491-9. PubMed

Galiatsatos P, Gibson BR, Rabiee A, et al. The glucoregulatory benefits of glucagon-like Peptide-1 (7-36) amide infusion during intensive insulin therapy in critically ill surgical patients: a pilot study. Crit Care Med. 2014;42:638-645. PubMed PMC

Ahren B. GLP-1 and extra-islet effects. Horm Metab Res. 2004;36:842-845. PubMed

Harkavyi A, Whitton PS. Glucagon-like peptide 1 receptor stimulation as a means of neuroprotection. Brit J Pharmacol. 2010;159:495-501. PubMed PMC

Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. New Engl J Med. 2008;358:2545-2559. PubMed PMC

Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. New Engl J Med. 2009;360:129-139. PubMed